Novartis NIBR Global Scholars Program – 2023 call for pre-proposals

Novartis, a global leader in drugs in various therapeutic fields (neurology, immunology, dermatology, cardiology, respiratory diseases, oncology, etc.), is one of the world's highest investing companies in research and development.
 
In late 2021, the Institut Pasteur decided to participate in the NIBR Global Scholars Program, a funding program for scientific projects run by Novartis, by becoming a partner of the Novartis Institutes for BioMedical Research (NIBR).

With six sites worldwide (in Switzerland, China and the United States) essentially focused on discovery and the fundamental mechanisms of disease, NIBR is the innovation engine of Novartis.

NIBR has introduced the NIBR Global Scholars Program (NGSP) to support scientists from partner institutions leading projects with potential in drug discovery.

Each project receives up to 1 million USD in funding over three years, along with drug-hunting expertise from dedicated NIBR scientific collaborators.

The program is based around the following scientific fields of interest*:
•    Biological products, gene therapy,
•    Complex models,
•    Disease mechanisms,
•    Proteins and drug design,
•    Regenerative medicine,
•    Specific targeting and characterization of tissues/cells,
•    Oncology and immuno-oncology.

*This information about the Novartis areas of interest is confidential and must not be communicated to third parties or published on external websites.
 

If you are interested in this call, please contact:
•    Vincent Charpentier (Technology Transfer Department/DARRI)
• Serge Pauillac (Innovation Detection and Funding Department/DARRI)

 

Calendar:
•     April 10, 2023: opening of the call for pre-proposals
•     May 5, 2023: deadline for submission of pre-proposals
•     Week of June 26, 2023: selection of finalists
•     July 3, 2023: opening of the call for proposals for finalists
•     July 28, 2023: deadline for the submission of full proposals
•     Mid-November 2023: winners informed

 

Eligibility criteria:
• This call for proposals is only open to scientists and professors (postdoctoral fellows and PhD students may not apply),
• Proposals involving any of the following are not eligible: projects (i) requiring the approval of a new biomedical research protocol by the IRB, (ii) involving clinical trials of drugs or products on human subjects, (iii) requiring procedures on patients and/or (iv) using identifiable clinical or patient data.